Moreover, the biosynthesis of serine and glycine affects cellular antioxidative capability and also promotes tumor growth [33]; The c-MYC oncogene activates the expression of glutaminase (GLS1/GLS2) and glutamine metabolism in cancer cells, and glutamine can be converted to glutamate even in hypoxia [34]. Here, MYC is linked to cancer.